Restricted accessResearch articleFirst published online 2022-10
Better late than never: initial experience of intra-arterial pulsed-urokinase-injection as a salvage therapy for refractory sudden sensorineural hearing loss
Cochlear vascular micro-thrombosis has been hypothesized as one of the pathogenic mechanisms for sudden sensorineural hearing loss (SSNHL) refractory to regular management. This study aimed to evaluate the feasibility and safety of intra-arterial pulsed-injection urokinase (IAPU) as a salvage therapy for SSNHL after the failure of conventional therapy.
Methods
We retrospectively reviewed our patient database to identify refractory SSNHL patients between November 2017 and July 2020. Study outcomes before and after the IAPU therapy were compared between IAPU and conventional therapy groups.
Results
Sixty-seven moderate-profound SSNHL patients (29 in IAUP group, 38 in control group) were included in this study. Compared to the control group, patients in the IAPU group showed more significant improvement in pure tone average (PTA) (34.2 ± 23.5 vs. 10.7 ± 13.1, p < 0.001) and degree of hearing recovery (total: 20.7% vs. 5.3%, partial: 24.1% vs. 10.5%, mild: 27.6% vs. 13.2% and non: 27.6% vs. 71.1%) 2 weeks after admission. In the IAPU group, a significant improvement of PTA (86.6 ± 11.5 vs. 54.6 ± 20.1 dB, p < 0.005) was observed on the first day after IAPU treatment.
Conclusion
In carefully selected SSNHL cases with a highly suspected vascular origin, IAPU is a safe and effective therapy when conventional treatments have failed. Despite the encouraging findings of our work, large studies are needed to better investigate the strengths and limitations of this salvage therapy.
AhmadzaiNKiltySWolfeD, et al.A protocol for a network meta-analysis of interventions to treat patients with sudden sensorineural hearing loss. Syst Rev2018; 7.
4.
KorpinarSAlkanZYigitO, et al.Factors influencing the outcome of idiopathic sudden sensorineural hearing loss treated with hyperbaric oxygen therapy. Eur Arch Otorhinolaryngol2011; 268: 41–47.
5.
ChauJKChoJJWFritzDK. Evidence-based practice management of adult sensorineural hearing loss. Otolaryngol Clin North Am2012; 45: 941–958.
6.
ChenJLiangJOuJ, et al.Mental health in adults with sudden sensorineural hearing loss: An assessment of depressive symptoms and its correlates. J Psychosom Res2013; 75: 72–74.
KimJSLeeH. Inner ear dysfunction due to vertebrobasilar ischemic stroke. Semin Neurol2009; 29: 534–540.
9.
LinH-CChaoP-ZLeeH-C. Sudden sensorineural hearing loss increases the risk of stroke – A 5-year follow-up study. Stroke2008; 39: 2744–2748.
10.
HagenR. Fibrinolytic therapy in sudden deafness with recombinant tissue-type plasminogen activator. Hemorheologic and therapeutic effects. Laryngorhinootologie1991; 70: 353–358.
11.
MoraRDellepianeMMoraF, et al.The use of recombinant tissue-type plasminogen activator for the treatment of sudden and chronic hearing loss. Int Tinnitus J2005; 11: 181–184.
12.
MattleHPArnoldMGeorgiadisD, et al.Comparison of intraarterial and intravenous thrombolysis for ischemic stroke with hyperdense middle cerebral artery sign. Stroke2008; 39: 379–383.
13.
CicconeAValvassoriLPonzioM, et al.Intra-arterial or intravenous thrombolysis for acute ischemic stroke? The SYNTHESIS pilot trial. J Neurointerv Surg2010; 2: 74–79.
14.
XieSQiangQMeiL, et al.Multivariate analysis of prognostic factors for idiopathic sudden sensorineural hearing loss treated with adjuvant hyperbaric oxygen therapy. Eur Arch Otorhinolaryngol2018; 275: 47–51.
15.
KooJWChangMYYunSC, et al.The efficacy and safety of systemic injection of Ginkgo biloba extract, EGb761, in idiopathic sudden sensorineural hearing loss: a randomized placebo-controlled clinical trial. Eur Arch Otorhinolaryngol2016; 273: 2433–2441.
16.
HaynesDSO’MalleyMCohenS, et al.Intratympanic dexamethasone for sudden sensorineural hearing loss after failure of systemic therapy. Laryngoscope2007; 117: 3–15.
17.
MelnickW. American National Standard specifications for audiometers. ASHA1971; 13: 203–206.
18.
NewmanCWJacobsonGPSpitzerJB. Development of the Tinnitus Handicap Inventory. Arch Otolaryngol Head Neck Surg1996; 122: 143–148.
19.
LeeHYKimD-KParkY-H, et al.Prognostic factors for profound sudden idiopathic sensorineural hearing loss: a multicenter retrospective study. Eur Arch Otorhinolaryngol2017; 274: 143–149.
20.
KangWSYangCJShimM, et al.Prognostic factors for recovery from sudden sensorineural hearing loss: A retrospective study. J Audiol Otol2017; 21: 9–15.
AjdukJRiesMTroticR, et al.Hyperbaric oxygen therapy as salvage therapy for sudden sensorineural hearing loss. J Int Adv Otol2017; 13: 61–64.
23.
LiHFengGWangH, et al.Intratympanic steroid therapy as a salvage treatment for sudden sensorineural hearing loss after failure of conventional therapy: A meta-analysis of randomized, controlled trials. Clin Ther2015; 37: 178–187.
24.
LeeHSLeeYJKangBS, et al.A clinical analysis of sudden sensorineural hearing loss cases. Korean J Audiol2014; 18: 69–75.
25.
LeeHBalohRW. Sudden deafness in vertebrobasilar ischemia: clinical features, vascular topographical patterns and long-term outcome. J Neurol Sci2005; 228: 99–104.
26.
ZadehMHStorperISSpitzerJB. Diagnosis and treatment of sudden-onset sensorineural hearing loss: A study of 51 patients. Otolaryngol Head Neck Surg2003; 128: 92–98.
27.
RudackCLangerCStollW, et al.Vascular risk factors in sudden hearing loss. Thromb Haemost2006; 95: 454–461.
28.
TruneDRNguyen-HuynhA. Vascular pathophysiology in hearing disorders. Semin Hear2012; 33: 242–250.
29.
ChauJKLinJRJAtashbandS, et al.Systematic review of the evidence for the etiology of adult sudden sensorineural hearing loss. Laryngoscope2010; 120: 1011–1021.
30.
SauvagetEKiciSKaniaR, et al.Vertebrobasilar occlusive disorders presenting as sudden sensorineural hearing loss. Laryngoscope2004; 114: 327–332.
31.
KimJHRohKJSuhSH, et al.Improvement of sudden bilateral hearing loss after vertebral artery stenting (Reprinted). J Neurointerv Surg2016; 8: E12–EU4.
32.
BooksteinJJFellmethBRobertsA, et al.Pulsed-spray pharmacomechanical thrombolysis: preliminary clinical results. AJR Am J Roentgenol1989; 152: 1097–1100.
33.
BooksteinJJValjiKRobertsAC. Pulsed versus conventional thrombolytic infusion techniques. Radiology1994; 193: 318–320.
34.
SchumacherMSchmidtDWakhlooAK. Intra-arterial fibrinolytic therapy in central retinal artery occlusion. Neuroradiology1993; 35: 600–605.
35.
WeberJRemondaLMattleHP, et al.Selective intra-arterial fibrinolysis of acute central retinal artery occlusion. Stroke1998; 29: 2076–2079.
36.
DingXZhangXHuangZ, et al.The characteristic and short-term prognosis of tinnitus associated with sudden sensorineural hearing loss. Neural Plast2018; 2018: 6059697.
37.
Di NardoWCianfroneFScorpecciA, et al.Transtympanic electrical stimulation for immediate and long-term tinnitus suppression. Int Tinnitus J2009; 15: 100–106.
38.
RamosAPoloRMasgoretE, et al.Cochlear implant in patients with sudden unilateral sensorineural hearing loss and associated tinnitus. Acta Otorrinolaringol Esp2012; 63: 15–20.
